nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—ABCC4—Fluorouracil—urinary bladder cancer	0.255	0.527	CbGbCtD
Oseltamivir—ABCC4—Methotrexate—urinary bladder cancer	0.141	0.291	CbGbCtD
Oseltamivir—SLC22A8—Methotrexate—urinary bladder cancer	0.0878	0.182	CbGbCtD
Oseltamivir—NEU1—prostate gland—urinary bladder cancer	0.0196	0.135	CbGeAlD
Oseltamivir—NEU1—seminal vesicle—urinary bladder cancer	0.0166	0.114	CbGeAlD
Oseltamivir—SLC22A8—urine—urinary bladder cancer	0.0147	0.101	CbGeAlD
Oseltamivir—NEU1—smooth muscle tissue—urinary bladder cancer	0.0139	0.0958	CbGeAlD
Oseltamivir—NEU1—urethra—urinary bladder cancer	0.0131	0.0906	CbGeAlD
Oseltamivir—NEU1—vagina—urinary bladder cancer	0.00968	0.0668	CbGeAlD
Oseltamivir—CES1—prostate gland—urinary bladder cancer	0.00788	0.0544	CbGeAlD
Oseltamivir—NEU1—lymph node—urinary bladder cancer	0.00626	0.0432	CbGeAlD
Oseltamivir—SLC15A1—epithelium—urinary bladder cancer	0.00538	0.0371	CbGeAlD
Oseltamivir—ABCC4—prostate gland—urinary bladder cancer	0.00531	0.0366	CbGeAlD
Oseltamivir—SLC22A8—prostate gland—urinary bladder cancer	0.00526	0.0363	CbGeAlD
Oseltamivir—SLC15A1—renal system—urinary bladder cancer	0.00499	0.0344	CbGeAlD
Oseltamivir—CES1—female reproductive system—urinary bladder cancer	0.0043	0.0297	CbGeAlD
Oseltamivir—CES1—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.00397	0.0583	CbGpPWpGaD
Oseltamivir—ABCC4—renal system—urinary bladder cancer	0.00362	0.025	CbGeAlD
Oseltamivir—SLC15A1—vagina—urinary bladder cancer	0.00361	0.0249	CbGeAlD
Oseltamivir—SLC22A8—renal system—urinary bladder cancer	0.00359	0.0248	CbGeAlD
Oseltamivir—CES1—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.0031	0.0455	CbGpPWpGaD
Oseltamivir—ABCC4—female reproductive system—urinary bladder cancer	0.0029	0.02	CbGeAlD
Oseltamivir—CES1—lymph node—urinary bladder cancer	0.00252	0.0174	CbGeAlD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.00214	0.0315	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—XRCC1—urinary bladder cancer	0.00182	0.0268	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—UGT2B7—urinary bladder cancer	0.00182	0.0268	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.00179	0.0264	CbGpPWpGaD
Oseltamivir—ABCC4—lymph node—urinary bladder cancer	0.00169	0.0117	CbGeAlD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.00167	0.0246	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.00167	0.0245	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—RRM2—urinary bladder cancer	0.00164	0.0241	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.00157	0.023	CbGpPWpGaD
Oseltamivir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00156	0.0229	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00124	0.0182	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—UGT2B7—urinary bladder cancer	0.000985	0.0145	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.000969	0.0142	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—CCNE1—urinary bladder cancer	0.000968	0.0142	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—TYMS—urinary bladder cancer	0.00095	0.014	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000938	0.0138	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—CDX2—urinary bladder cancer	0.000901	0.0132	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.0009	0.0132	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000846	0.0124	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000796	0.0117	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—PLAU—urinary bladder cancer	0.000784	0.0115	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—ATM—urinary bladder cancer	0.000744	0.0109	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000708	0.0104	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTZ1—urinary bladder cancer	0.000706	0.0104	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—NQO1—urinary bladder cancer	0.000704	0.0103	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CDX2—urinary bladder cancer	0.000682	0.01	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTO2—urinary bladder cancer	0.00067	0.00984	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NAT1—urinary bladder cancer	0.00067	0.00984	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000659	0.00968	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—CREBBP—urinary bladder cancer	0.000647	0.00951	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—RB1—urinary bladder cancer	0.000644	0.00947	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—UGT2B7—urinary bladder cancer	0.000612	0.009	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000595	0.00874	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—GSTP1—urinary bladder cancer	0.000587	0.00863	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—CDKN2A—urinary bladder cancer	0.000566	0.00833	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000565	0.00831	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP4B1—urinary bladder cancer	0.000551	0.0081	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—GSTM1—urinary bladder cancer	0.00054	0.00793	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTZ1—urinary bladder cancer	0.000535	0.00787	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—SLC19A1—urinary bladder cancer	0.000521	0.00765	CbGpPWpGaD
Oseltamivir—Asthma—Methotrexate—urinary bladder cancer	0.000514	0.00169	CcSEcCtD
Oseltamivir—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.000514	0.00169	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000512	0.00169	CcSEcCtD
Oseltamivir—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000509	0.00167	CcSEcCtD
Oseltamivir—Insomnia—Fluorouracil—urinary bladder cancer	0.000508	0.00167	CcSEcCtD
Oseltamivir—NEU1—Metabolism—PRSS3—urinary bladder cancer	0.000507	0.00746	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTO2—urinary bladder cancer	0.000507	0.00746	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NAT1—urinary bladder cancer	0.000507	0.00746	CbGpPWpGaD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000506	0.00166	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000501	0.00165	CcSEcCtD
Oseltamivir—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000501	0.00165	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000499	0.00734	CbGpPWpGaD
Oseltamivir—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000498	0.00164	CcSEcCtD
Oseltamivir—Face oedema—Doxorubicin—urinary bladder cancer	0.000497	0.00164	CcSEcCtD
Oseltamivir—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000495	0.00163	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000494	0.00162	CcSEcCtD
Oseltamivir—Fatigue—Gemcitabine—urinary bladder cancer	0.000493	0.00162	CcSEcCtD
Oseltamivir—Confusional state—Etoposide—urinary bladder cancer	0.000492	0.00162	CcSEcCtD
Oseltamivir—Pain—Gemcitabine—urinary bladder cancer	0.000489	0.00161	CcSEcCtD
Oseltamivir—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000488	0.00161	CcSEcCtD
Oseltamivir—Asthenia—Thiotepa—urinary bladder cancer	0.000488	0.0016	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000486	0.0016	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000485	0.0016	CcSEcCtD
Oseltamivir—Infection—Etoposide—urinary bladder cancer	0.000485	0.0016	CcSEcCtD
Oseltamivir—Influenza—Epirubicin—urinary bladder cancer	0.000481	0.00158	CcSEcCtD
Oseltamivir—Asthma—Epirubicin—urinary bladder cancer	0.000481	0.00158	CcSEcCtD
Oseltamivir—Pain—Fluorouracil—urinary bladder cancer	0.000481	0.00158	CcSEcCtD
Oseltamivir—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000478	0.00157	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000478	0.00157	CcSEcCtD
Oseltamivir—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000476	0.00157	CcSEcCtD
Oseltamivir—Skin disorder—Etoposide—urinary bladder cancer	0.000474	0.00156	CcSEcCtD
Oseltamivir—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000471	0.00155	CcSEcCtD
Oseltamivir—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000471	0.00155	CcSEcCtD
Oseltamivir—Angina pectoris—Epirubicin—urinary bladder cancer	0.000469	0.00154	CcSEcCtD
Oseltamivir—Diarrhoea—Thiotepa—urinary bladder cancer	0.000465	0.00153	CcSEcCtD
Oseltamivir—NEU2—Metabolism—UGT2B7—urinary bladder cancer	0.000464	0.00682	CbGpPWpGaD
Oseltamivir—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000464	0.00153	CcSEcCtD
Oseltamivir—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000463	0.00152	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—CDKN1A—urinary bladder cancer	0.000463	0.0068	CbGpPWpGaD
Oseltamivir—Bronchitis—Epirubicin—urinary bladder cancer	0.000463	0.00152	CcSEcCtD
Oseltamivir—Pneumonia—Methotrexate—urinary bladder cancer	0.000461	0.00152	CcSEcCtD
Oseltamivir—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000461	0.00152	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00046	0.00151	CcSEcCtD
Oseltamivir—Infestation—Methotrexate—urinary bladder cancer	0.000459	0.00151	CcSEcCtD
Oseltamivir—Infestation NOS—Methotrexate—urinary bladder cancer	0.000459	0.00151	CcSEcCtD
Oseltamivir—Pain—Cisplatin—urinary bladder cancer	0.000456	0.0015	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000455	0.0015	CcSEcCtD
Oseltamivir—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000452	0.00149	CcSEcCtD
Oseltamivir—Dizziness—Thiotepa—urinary bladder cancer	0.000449	0.00148	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000447	0.00147	CcSEcCtD
Oseltamivir—Urticaria—Fluorouracil—urinary bladder cancer	0.000447	0.00147	CcSEcCtD
Oseltamivir—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000446	0.00147	CcSEcCtD
Oseltamivir—Influenza—Doxorubicin—urinary bladder cancer	0.000445	0.00147	CcSEcCtD
Oseltamivir—Asthma—Doxorubicin—urinary bladder cancer	0.000445	0.00147	CcSEcCtD
Oseltamivir—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000444	0.00146	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—EP300—urinary bladder cancer	0.00044	0.00647	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000439	0.00145	CcSEcCtD
Oseltamivir—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000434	0.00143	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000434	0.00143	CcSEcCtD
Oseltamivir—Epistaxis—Methotrexate—urinary bladder cancer	0.000433	0.00142	CcSEcCtD
Oseltamivir—Vomiting—Thiotepa—urinary bladder cancer	0.000432	0.00142	CcSEcCtD
Oseltamivir—Pneumonia—Epirubicin—urinary bladder cancer	0.000432	0.00142	CcSEcCtD
Oseltamivir—Infestation NOS—Epirubicin—urinary bladder cancer	0.000429	0.00141	CcSEcCtD
Oseltamivir—Infestation—Epirubicin—urinary bladder cancer	0.000429	0.00141	CcSEcCtD
Oseltamivir—Rash—Thiotepa—urinary bladder cancer	0.000429	0.00141	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000429	0.0063	CbGpPWpGaD
Oseltamivir—Bronchitis—Doxorubicin—urinary bladder cancer	0.000428	0.00141	CcSEcCtD
Oseltamivir—Dermatitis—Thiotepa—urinary bladder cancer	0.000428	0.00141	CcSEcCtD
Oseltamivir—Headache—Thiotepa—urinary bladder cancer	0.000426	0.0014	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000425	0.0014	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000422	0.00139	CcSEcCtD
Oseltamivir—Body temperature increased—Cisplatin—urinary bladder cancer	0.000421	0.00139	CcSEcCtD
Oseltamivir—Fatigue—Etoposide—urinary bladder cancer	0.000421	0.00139	CcSEcCtD
Oseltamivir—Jaundice—Epirubicin—urinary bladder cancer	0.000418	0.00138	CcSEcCtD
Oseltamivir—NEU2—Metabolism—CYP4B1—urinary bladder cancer	0.000418	0.00614	CbGpPWpGaD
Oseltamivir—Pain—Etoposide—urinary bladder cancer	0.000418	0.00137	CcSEcCtD
Oseltamivir—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000417	0.00137	CcSEcCtD
Oseltamivir—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000414	0.00136	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000414	0.00136	CcSEcCtD
Oseltamivir—Hepatitis—Methotrexate—urinary bladder cancer	0.000412	0.00135	CcSEcCtD
Oseltamivir—Asthenia—Gemcitabine—urinary bladder cancer	0.00041	0.00135	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000407	0.00598	CbGpPWpGaD
Oseltamivir—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000406	0.00134	CcSEcCtD
Oseltamivir—NEU1—Metabolism—TYMP—urinary bladder cancer	0.000406	0.00596	CbGpPWpGaD
Oseltamivir—Epistaxis—Epirubicin—urinary bladder cancer	0.000405	0.00133	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000404	0.00594	CbGpPWpGaD
Oseltamivir—Nausea—Thiotepa—urinary bladder cancer	0.000404	0.00133	CcSEcCtD
Oseltamivir—Sinusitis—Epirubicin—urinary bladder cancer	0.000403	0.00132	CcSEcCtD
Oseltamivir—Feeling abnormal—Etoposide—urinary bladder cancer	0.000402	0.00132	CcSEcCtD
Oseltamivir—Pneumonia—Doxorubicin—urinary bladder cancer	0.000399	0.00131	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000399	0.00131	CcSEcCtD
Oseltamivir—Infestation—Doxorubicin—urinary bladder cancer	0.000397	0.00131	CcSEcCtD
Oseltamivir—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000397	0.00131	CcSEcCtD
Oseltamivir—Visual impairment—Methotrexate—urinary bladder cancer	0.000397	0.00131	CcSEcCtD
Oseltamivir—NEU2—Metabolism—SLC19A1—urinary bladder cancer	0.000395	0.0058	CbGpPWpGaD
Oseltamivir—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000394	0.0013	CcSEcCtD
Oseltamivir—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000393	0.00129	CcSEcCtD
Oseltamivir—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000391	0.00129	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.00039	0.00573	CbGpPWpGaD
Oseltamivir—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000389	0.00128	CcSEcCtD
Oseltamivir—Urticaria—Etoposide—urinary bladder cancer	0.000388	0.00128	CcSEcCtD
Oseltamivir—Jaundice—Doxorubicin—urinary bladder cancer	0.000387	0.00127	CcSEcCtD
Oseltamivir—Abdominal pain—Etoposide—urinary bladder cancer	0.000386	0.00127	CcSEcCtD
Oseltamivir—Body temperature increased—Etoposide—urinary bladder cancer	0.000386	0.00127	CcSEcCtD
Oseltamivir—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000386	0.00127	CcSEcCtD
Oseltamivir—Hepatitis—Epirubicin—urinary bladder cancer	0.000385	0.00127	CcSEcCtD
Oseltamivir—Eye disorder—Methotrexate—urinary bladder cancer	0.000385	0.00127	CcSEcCtD
Oseltamivir—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000385	0.00127	CcSEcCtD
Oseltamivir—NEU2—Metabolism—PRSS3—urinary bladder cancer	0.000385	0.00565	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—MYC—urinary bladder cancer	0.000384	0.00564	CbGpPWpGaD
Oseltamivir—Asthenia—Cisplatin—urinary bladder cancer	0.000382	0.00126	CcSEcCtD
Oseltamivir—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000382	0.00126	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—NQO1—urinary bladder cancer	0.00038	0.00559	CbGpPWpGaD
Oseltamivir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000376	0.00124	CcSEcCtD
Oseltamivir—Epistaxis—Doxorubicin—urinary bladder cancer	0.000375	0.00123	CcSEcCtD
Oseltamivir—Sinusitis—Doxorubicin—urinary bladder cancer	0.000373	0.00123	CcSEcCtD
Oseltamivir—Immune system disorder—Methotrexate—urinary bladder cancer	0.000372	0.00122	CcSEcCtD
Oseltamivir—Dizziness—Fluorouracil—urinary bladder cancer	0.000372	0.00122	CcSEcCtD
Oseltamivir—Visual impairment—Epirubicin—urinary bladder cancer	0.000371	0.00122	CcSEcCtD
Oseltamivir—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000371	0.00122	CcSEcCtD
Oseltamivir—NEU1—Metabolism—NAT2—urinary bladder cancer	0.000367	0.00539	CbGpPWpGaD
Oseltamivir—Diarrhoea—Cisplatin—urinary bladder cancer	0.000365	0.0012	CcSEcCtD
Oseltamivir—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000364	0.0012	CcSEcCtD
Oseltamivir—Vomiting—Gemcitabine—urinary bladder cancer	0.000364	0.0012	CcSEcCtD
Oseltamivir—Mental disorder—Methotrexate—urinary bladder cancer	0.000361	0.00119	CcSEcCtD
Oseltamivir—Rash—Gemcitabine—urinary bladder cancer	0.000361	0.00119	CcSEcCtD
Oseltamivir—Dermatitis—Gemcitabine—urinary bladder cancer	0.00036	0.00119	CcSEcCtD
Oseltamivir—Eye disorder—Epirubicin—urinary bladder cancer	0.00036	0.00118	CcSEcCtD
Oseltamivir—Hypersensitivity—Etoposide—urinary bladder cancer	0.00036	0.00118	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00036	0.00529	CbGpPWpGaD
Oseltamivir—Headache—Gemcitabine—urinary bladder cancer	0.000358	0.00118	CcSEcCtD
Oseltamivir—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000358	0.00118	CcSEcCtD
Oseltamivir—Vomiting—Fluorouracil—urinary bladder cancer	0.000357	0.00118	CcSEcCtD
Oseltamivir—Hepatitis—Doxorubicin—urinary bladder cancer	0.000356	0.00117	CcSEcCtD
Oseltamivir—Rash—Fluorouracil—urinary bladder cancer	0.000354	0.00117	CcSEcCtD
Oseltamivir—Dermatitis—Fluorouracil—urinary bladder cancer	0.000354	0.00117	CcSEcCtD
Oseltamivir—Headache—Fluorouracil—urinary bladder cancer	0.000352	0.00116	CcSEcCtD
Oseltamivir—Asthenia—Etoposide—urinary bladder cancer	0.00035	0.00115	CcSEcCtD
Oseltamivir—Immune system disorder—Epirubicin—urinary bladder cancer	0.000348	0.00115	CcSEcCtD
Oseltamivir—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000347	0.00114	CcSEcCtD
Oseltamivir—Back pain—Methotrexate—urinary bladder cancer	0.000347	0.00114	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000345	0.00507	CbGpPWpGaD
Oseltamivir—Arrhythmia—Epirubicin—urinary bladder cancer	0.000344	0.00113	CcSEcCtD
Oseltamivir—Visual impairment—Doxorubicin—urinary bladder cancer	0.000344	0.00113	CcSEcCtD
Oseltamivir—Nausea—Gemcitabine—urinary bladder cancer	0.00034	0.00112	CcSEcCtD
Oseltamivir—Vomiting—Cisplatin—urinary bladder cancer	0.000339	0.00112	CcSEcCtD
Oseltamivir—Mental disorder—Epirubicin—urinary bladder cancer	0.000337	0.00111	CcSEcCtD
Oseltamivir—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000337	0.00111	CcSEcCtD
Oseltamivir—Rash—Cisplatin—urinary bladder cancer	0.000336	0.00111	CcSEcCtD
Oseltamivir—Dermatitis—Cisplatin—urinary bladder cancer	0.000336	0.0011	CcSEcCtD
Oseltamivir—Diarrhoea—Etoposide—urinary bladder cancer	0.000334	0.0011	CcSEcCtD
Oseltamivir—Nausea—Fluorouracil—urinary bladder cancer	0.000334	0.0011	CcSEcCtD
Oseltamivir—Eye disorder—Doxorubicin—urinary bladder cancer	0.000333	0.0011	CcSEcCtD
Oseltamivir—Anaemia—Methotrexate—urinary bladder cancer	0.000331	0.00109	CcSEcCtD
Oseltamivir—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000331	0.00109	CcSEcCtD
Oseltamivir—Back pain—Epirubicin—urinary bladder cancer	0.000324	0.00107	CcSEcCtD
Oseltamivir—Dizziness—Etoposide—urinary bladder cancer	0.000323	0.00106	CcSEcCtD
Oseltamivir—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000322	0.00106	CcSEcCtD
Oseltamivir—Vertigo—Methotrexate—urinary bladder cancer	0.000322	0.00106	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000321	0.00472	CbGpPWpGaD
Oseltamivir—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000321	0.00106	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—IGF1—urinary bladder cancer	0.000321	0.00471	CbGpPWpGaD
Oseltamivir—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000318	0.00105	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—GSTP1—urinary bladder cancer	0.000317	0.00466	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—RRM2—urinary bladder cancer	0.000317	0.00465	CbGpPWpGaD
Oseltamivir—Nausea—Cisplatin—urinary bladder cancer	0.000317	0.00104	CcSEcCtD
Oseltamivir—Cough—Methotrexate—urinary bladder cancer	0.000313	0.00103	CcSEcCtD
Oseltamivir—Mental disorder—Doxorubicin—urinary bladder cancer	0.000312	0.00103	CcSEcCtD
Oseltamivir—Convulsion—Methotrexate—urinary bladder cancer	0.00031	0.00102	CcSEcCtD
Oseltamivir—Vomiting—Etoposide—urinary bladder cancer	0.00031	0.00102	CcSEcCtD
Oseltamivir—Anaemia—Epirubicin—urinary bladder cancer	0.00031	0.00102	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000308	0.00453	CbGpPWpGaD
Oseltamivir—Agitation—Epirubicin—urinary bladder cancer	0.000308	0.00101	CcSEcCtD
Oseltamivir—Rash—Etoposide—urinary bladder cancer	0.000308	0.00101	CcSEcCtD
Oseltamivir—Dermatitis—Etoposide—urinary bladder cancer	0.000308	0.00101	CcSEcCtD
Oseltamivir—NEU2—Metabolism—TYMP—urinary bladder cancer	0.000307	0.00452	CbGpPWpGaD
Oseltamivir—Headache—Etoposide—urinary bladder cancer	0.000306	0.00101	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.000305	0.00449	CbGpPWpGaD
Oseltamivir—Arthralgia—Methotrexate—urinary bladder cancer	0.000305	0.001	CcSEcCtD
Oseltamivir—Myalgia—Methotrexate—urinary bladder cancer	0.000305	0.001	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000303	0.000997	CcSEcCtD
Oseltamivir—Vertigo—Epirubicin—urinary bladder cancer	0.000301	0.000992	CcSEcCtD
Oseltamivir—Back pain—Doxorubicin—urinary bladder cancer	0.0003	0.000988	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000295	0.00434	CbGpPWpGaD
Oseltamivir—Confusional state—Methotrexate—urinary bladder cancer	0.000295	0.00097	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ENO2—urinary bladder cancer	0.000293	0.00431	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—HPGDS—urinary bladder cancer	0.000293	0.00431	CbGpPWpGaD
Oseltamivir—Cough—Epirubicin—urinary bladder cancer	0.000293	0.000963	CcSEcCtD
Oseltamivir—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000292	0.000962	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000292	0.0043	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000292	0.00429	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—GSTM1—urinary bladder cancer	0.000291	0.00428	CbGpPWpGaD
Oseltamivir—Convulsion—Epirubicin—urinary bladder cancer	0.000291	0.000956	CcSEcCtD
Oseltamivir—Infection—Methotrexate—urinary bladder cancer	0.000291	0.000956	CcSEcCtD
Oseltamivir—Nausea—Etoposide—urinary bladder cancer	0.00029	0.000954	CcSEcCtD
Oseltamivir—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000287	0.000944	CcSEcCtD
Oseltamivir—Anaemia—Doxorubicin—urinary bladder cancer	0.000287	0.000944	CcSEcCtD
Oseltamivir—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000286	0.000942	CcSEcCtD
Oseltamivir—Arthralgia—Epirubicin—urinary bladder cancer	0.000286	0.00094	CcSEcCtD
Oseltamivir—Myalgia—Epirubicin—urinary bladder cancer	0.000286	0.00094	CcSEcCtD
Oseltamivir—Agitation—Doxorubicin—urinary bladder cancer	0.000285	0.000938	CcSEcCtD
Oseltamivir—Anxiety—Epirubicin—urinary bladder cancer	0.000285	0.000936	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GSTT1—urinary bladder cancer	0.000284	0.00418	CbGpPWpGaD
Oseltamivir—Skin disorder—Methotrexate—urinary bladder cancer	0.000284	0.000935	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000284	0.000933	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00028	0.00412	CbGpPWpGaD
Oseltamivir—Vertigo—Doxorubicin—urinary bladder cancer	0.000279	0.000917	CcSEcCtD
Oseltamivir—NEU2—Metabolism—NAT2—urinary bladder cancer	0.000278	0.00409	CbGpPWpGaD
Oseltamivir—Confusional state—Epirubicin—urinary bladder cancer	0.000276	0.000908	CcSEcCtD
Oseltamivir—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000274	0.000901	CcSEcCtD
Oseltamivir—Infection—Epirubicin—urinary bladder cancer	0.000272	0.000895	CcSEcCtD
Oseltamivir—Cough—Doxorubicin—urinary bladder cancer	0.000271	0.000891	CcSEcCtD
Oseltamivir—Convulsion—Doxorubicin—urinary bladder cancer	0.000269	0.000885	CcSEcCtD
Oseltamivir—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000268	0.000883	CcSEcCtD
Oseltamivir—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000268	0.000882	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000266	0.000877	CcSEcCtD
Oseltamivir—Skin disorder—Epirubicin—urinary bladder cancer	0.000266	0.000875	CcSEcCtD
Oseltamivir—Insomnia—Methotrexate—urinary bladder cancer	0.000265	0.00087	CcSEcCtD
Oseltamivir—Myalgia—Doxorubicin—urinary bladder cancer	0.000264	0.000869	CcSEcCtD
Oseltamivir—Arthralgia—Doxorubicin—urinary bladder cancer	0.000264	0.000869	CcSEcCtD
Oseltamivir—Anxiety—Doxorubicin—urinary bladder cancer	0.000263	0.000866	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000262	0.000863	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00026	0.00382	CbGpPWpGaD
Oseltamivir—Dyspepsia—Methotrexate—urinary bladder cancer	0.000257	0.000847	CcSEcCtD
Oseltamivir—Confusional state—Doxorubicin—urinary bladder cancer	0.000255	0.00084	CcSEcCtD
Oseltamivir—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000253	0.000833	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000252	0.000831	CcSEcCtD
Oseltamivir—Fatigue—Methotrexate—urinary bladder cancer	0.000252	0.00083	CcSEcCtD
Oseltamivir—Infection—Doxorubicin—urinary bladder cancer	0.000252	0.000828	CcSEcCtD
Oseltamivir—Pain—Methotrexate—urinary bladder cancer	0.00025	0.000823	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000249	0.000821	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000249	0.00366	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000248	0.000817	CcSEcCtD
Oseltamivir—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000248	0.000816	CcSEcCtD
Oseltamivir—Insomnia—Epirubicin—urinary bladder cancer	0.000248	0.000815	CcSEcCtD
Oseltamivir—Skin disorder—Doxorubicin—urinary bladder cancer	0.000246	0.000809	CcSEcCtD
Oseltamivir—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000241	0.000793	CcSEcCtD
Oseltamivir—Dyspepsia—Epirubicin—urinary bladder cancer	0.000241	0.000793	CcSEcCtD
Oseltamivir—NEU2—Metabolism—RRM2—urinary bladder cancer	0.00024	0.00353	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000239	0.000787	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—IGF1—urinary bladder cancer	0.000239	0.00351	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000238	0.0035	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NQO1—urinary bladder cancer	0.000236	0.00347	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000236	0.000778	CcSEcCtD
Oseltamivir—Fatigue—Epirubicin—urinary bladder cancer	0.000236	0.000777	CcSEcCtD
Oseltamivir—Pain—Epirubicin—urinary bladder cancer	0.000234	0.00077	CcSEcCtD
Oseltamivir—Urticaria—Methotrexate—urinary bladder cancer	0.000232	0.000765	CcSEcCtD
Oseltamivir—Abdominal pain—Methotrexate—urinary bladder cancer	0.000231	0.000761	CcSEcCtD
Oseltamivir—Body temperature increased—Methotrexate—urinary bladder cancer	0.000231	0.000761	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000231	0.000759	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000229	0.00337	CbGpPWpGaD
Oseltamivir—Insomnia—Doxorubicin—urinary bladder cancer	0.000229	0.000754	CcSEcCtD
Oseltamivir—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000226	0.000742	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000224	0.000737	CcSEcCtD
Oseltamivir—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000223	0.000734	CcSEcCtD
Oseltamivir—NEU2—Metabolism—HPGDS—urinary bladder cancer	0.000222	0.00327	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ENO2—urinary bladder cancer	0.000222	0.00327	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000221	0.00325	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000219	0.000719	CcSEcCtD
Oseltamivir—Fatigue—Doxorubicin—urinary bladder cancer	0.000218	0.000719	CcSEcCtD
Oseltamivir—Urticaria—Epirubicin—urinary bladder cancer	0.000217	0.000716	CcSEcCtD
Oseltamivir—Pain—Doxorubicin—urinary bladder cancer	0.000217	0.000713	CcSEcCtD
Oseltamivir—Abdominal pain—Epirubicin—urinary bladder cancer	0.000216	0.000712	CcSEcCtD
Oseltamivir—Body temperature increased—Epirubicin—urinary bladder cancer	0.000216	0.000712	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GSTT1—urinary bladder cancer	0.000216	0.00317	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000215	0.000709	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000212	0.00312	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000212	0.00312	CbGpPWpGaD
Oseltamivir—Asthenia—Methotrexate—urinary bladder cancer	0.00021	0.000691	CcSEcCtD
Oseltamivir—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000209	0.000687	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000207	0.000681	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000203	0.00299	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000202	0.000664	CcSEcCtD
Oseltamivir—Urticaria—Doxorubicin—urinary bladder cancer	0.000201	0.000662	CcSEcCtD
Oseltamivir—Abdominal pain—Doxorubicin—urinary bladder cancer	0.0002	0.000659	CcSEcCtD
Oseltamivir—Body temperature increased—Doxorubicin—urinary bladder cancer	0.0002	0.000659	CcSEcCtD
Oseltamivir—Diarrhoea—Methotrexate—urinary bladder cancer	0.0002	0.000659	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.0002	0.00294	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTP1—urinary bladder cancer	0.000197	0.0029	CbGpPWpGaD
Oseltamivir—Asthenia—Epirubicin—urinary bladder cancer	0.000196	0.000646	CcSEcCtD
Oseltamivir—Dizziness—Methotrexate—urinary bladder cancer	0.000193	0.000636	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—CXCL8—urinary bladder cancer	0.000192	0.00283	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000191	0.0028	CbGpPWpGaD
Oseltamivir—Diarrhoea—Epirubicin—urinary bladder cancer	0.000187	0.000616	CcSEcCtD
Oseltamivir—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000187	0.000614	CcSEcCtD
Oseltamivir—Vomiting—Methotrexate—urinary bladder cancer	0.000186	0.000612	CcSEcCtD
Oseltamivir—Rash—Methotrexate—urinary bladder cancer	0.000184	0.000607	CcSEcCtD
Oseltamivir—Dermatitis—Methotrexate—urinary bladder cancer	0.000184	0.000606	CcSEcCtD
Oseltamivir—NEU1—Metabolism—TYMS—urinary bladder cancer	0.000183	0.00269	CbGpPWpGaD
Oseltamivir—Headache—Methotrexate—urinary bladder cancer	0.000183	0.000603	CcSEcCtD
Oseltamivir—Asthenia—Doxorubicin—urinary bladder cancer	0.000182	0.000598	CcSEcCtD
Oseltamivir—NEU1—Metabolism—NCOR1—urinary bladder cancer	0.000181	0.00266	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTM1—urinary bladder cancer	0.000181	0.00266	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—IGF1—urinary bladder cancer	0.000181	0.00266	CbGpPWpGaD
Oseltamivir—Dizziness—Epirubicin—urinary bladder cancer	0.000181	0.000596	CcSEcCtD
Oseltamivir—NEU2—Metabolism—NQO1—urinary bladder cancer	0.000179	0.00263	CbGpPWpGaD
Oseltamivir—Vomiting—Epirubicin—urinary bladder cancer	0.000174	0.000573	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000174	0.00256	CbGpPWpGaD
Oseltamivir—Nausea—Methotrexate—urinary bladder cancer	0.000174	0.000572	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GPX1—urinary bladder cancer	0.000174	0.00255	CbGpPWpGaD
Oseltamivir—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000173	0.00057	CcSEcCtD
Oseltamivir—Rash—Epirubicin—urinary bladder cancer	0.000173	0.000568	CcSEcCtD
Oseltamivir—Dermatitis—Epirubicin—urinary bladder cancer	0.000172	0.000567	CcSEcCtD
Oseltamivir—Headache—Epirubicin—urinary bladder cancer	0.000171	0.000564	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ERCC2—urinary bladder cancer	0.00017	0.0025	CbGpPWpGaD
Oseltamivir—Dizziness—Doxorubicin—urinary bladder cancer	0.000167	0.000551	CcSEcCtD
Oseltamivir—Nausea—Epirubicin—urinary bladder cancer	0.000163	0.000535	CcSEcCtD
Oseltamivir—Vomiting—Doxorubicin—urinary bladder cancer	0.000161	0.00053	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000161	0.00237	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—MTHFR—urinary bladder cancer	0.00016	0.00235	CbGpPWpGaD
Oseltamivir—Rash—Doxorubicin—urinary bladder cancer	0.00016	0.000525	CcSEcCtD
Oseltamivir—Dermatitis—Doxorubicin—urinary bladder cancer	0.00016	0.000525	CcSEcCtD
Oseltamivir—Headache—Doxorubicin—urinary bladder cancer	0.000159	0.000522	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000152	0.00223	CbGpPWpGaD
Oseltamivir—Nausea—Doxorubicin—urinary bladder cancer	0.00015	0.000495	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GSTP1—urinary bladder cancer	0.000149	0.0022	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CXCL8—urinary bladder cancer	0.000146	0.00214	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000145	0.00213	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000143	0.0021	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	0.000142	0.00209	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—TYMS—urinary bladder cancer	0.000139	0.00204	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTM1—urinary bladder cancer	0.000137	0.00202	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NCOR1—urinary bladder cancer	0.000137	0.00202	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000137	0.00202	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GPX1—urinary bladder cancer	0.000132	0.00193	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	0.00013	0.00191	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PPARG—urinary bladder cancer	0.00013	0.00191	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ERCC2—urinary bladder cancer	0.000129	0.0019	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IFNA2—urinary bladder cancer	0.000127	0.00186	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CREBBP—urinary bladder cancer	0.000125	0.00183	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—MYC—urinary bladder cancer	0.000125	0.00183	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—MTHFR—urinary bladder cancer	0.000121	0.00178	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	0.000109	0.00161	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTGS2—urinary bladder cancer	0.000102	0.0015	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PPARG—urinary bladder cancer	9.84e-05	0.00145	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	9.54e-05	0.0014	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CREBBP—urinary bladder cancer	9.45e-05	0.00139	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PLAU—urinary bladder cancer	9e-05	0.00132	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTEN—urinary bladder cancer	8.91e-05	0.00131	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—EP300—urinary bladder cancer	8.5e-05	0.00125	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTGS2—urinary bladder cancer	7.74e-05	0.00114	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.53e-05	0.00111	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CREBBP—urinary bladder cancer	7.42e-05	0.00109	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IGF1—urinary bladder cancer	7.33e-05	0.00108	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTEN—urinary bladder cancer	6.75e-05	0.000992	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—RHOA—urinary bladder cancer	6.71e-05	0.000987	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.7e-05	0.000985	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—EP300—urinary bladder cancer	6.44e-05	0.000946	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.42e-05	0.000944	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IL2—urinary bladder cancer	5.63e-05	0.000828	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—EP300—urinary bladder cancer	5.05e-05	0.000743	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SRC—urinary bladder cancer	4.91e-05	0.000722	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—KRAS—urinary bladder cancer	4.07e-05	0.000598	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TP53—urinary bladder cancer	3.62e-05	0.000532	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—HRAS—urinary bladder cancer	3.46e-05	0.000508	CbGpPWpGaD
